Akums - About the company
Akums is a public company based in Delhi (India), founded in 2004 by Sandeep Jain and Sanjeev Jain. It operates as a CDMO focusing on spectrum of dosage forms and therapeutic segments. Akums has raised $70M in funding from Quadria Capital. The company has 893 active competitors, including 29 funded and 135 that have exited. Its top competitors include companies like Jubilant Life Sciences, Nivagen Pharmaceuticals and Leukocare.
Company Details
CDMO focusing on spectrum of dosage forms and therapeutic segments. It also manufactures and exports formulations in various dosage forms include oral solids, oral liquids, sterile, hormonal, ointments, cosmetics, Ayurvedic, and nutraceuticals. And also across a wide spectrum of other therapeutic segments, include respiratory, neurology, analgesics, cardiovascular, immunomodulators, and supportive care.
- Website
- www.akums.in/
- Email ID
- *****@akums.net
- Phone Number
- +91 **********
- Registered Address
- Unit 101, Plot No.4, 1st Floor, Mohan Place LSC, Block-C, Saraswati Vihar, North West, Delhi, Delhi, India, 110034
Key Metrics
Founded Year
2004
Location
Delhi, India
Stage
Public
Total Funding
$70M in 1 round
Latest Funding Round
Investors
Ranked
1st among 893 active competitors
Annual Revenue
₹1,000+ Cr as on Mar 31, 2026
Employee Count
1,802 as on Mar 31, 2026
Investment & Acquisitions
Similar Companies
Exit Details
Public
Legal entities associated with Akums
Akums is associated with 9 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
MEDIBOX PHARMA PRIVATE LIMITED CIN: U72900DL2016PTC399490 , India, Active | Aug 19, 2016 | ₹10 - ₹50 Cr (As on Mar 31, 2026) | - | |
AVHA LIFESCIENCES PRIVATE LIMITED CIN: U51909DL2017PTC325425 , India, Active | Oct 30, 2017 | 0 - ₹10 Cr (As on Mar 31, 2026) | 1 (As on Mar 01, 2022) | |
AKUMS FOUNDATION CIN: U85300DL2019NPL355543 , India, Active | Sep 25, 2019 | 0 - ₹10 Cr (As on Mar 31, 2026) | - | |
MAXCURE NUTRAVEDICS LIMITED CIN: U74899DL1994PLC057323 , India, Active | Feb 10, 1994 | ₹500 - ₹1,000 Cr (As on Mar 31, 2026) | 229 (As on May 01, 2026) | |
AKUMS HEALTHCARE LIMITED CIN: U24304DL2020PLC375098 , India, Active | Dec 29, 2020 | ₹50 - ₹100 Cr (As on Mar 31, 2026) | 230 (As on Jan 31, 2025) | |
AKOME LIFECARE PRIVATE LIMITED CIN: U24100DL2022PTC393711 , India, Active | Feb 11, 2022 | ₹10 - ₹50 Cr (As on Mar 31, 2025) | - | |
MALIK LIFESCIENCES PRIVATE LIMITED CIN: U63021DL2004PTC299408 , India, Active | Feb 05, 2004 | ₹500 - ₹1,000 Cr (As on Mar 31, 2026) | 400 (As on Jan 31, 2025) | |
AKUMS LIFESCIENCES LIMITED CIN: U24231CH1996PLC017755 , India, Amalgamated | Feb 22, 1996 | ₹100 - ₹500 Cr (As on Mar 31, 2023) | - | |
AKUMS DRUGS AND PHARMACEUTICALS LIMITED CIN: L24239DL2004PLC125888 , India, Active | Apr 19, 2004 | ₹1,000+ Cr (As on Mar 31, 2026) | 1707 (As on May 01, 2026) |
Akums's IPO details
Akums got listed on Aug 06, 2024.
Click here to take a look at Akums's IPO in detail
Sign up to download Akums' company profile
Akums's funding and investors
Akums has raised a total funding of $70M over 1 round. Its latest funding round was a PE round on Nov 13, 2019 for $*****. 1 investor participated in its latest round. Akums has 1 institutional investor.
Here is the list of recent funding rounds of Akums:
Date of Funding | Funding Amount | Round Name | Post-Money Valuation | Revenue Multiple | Lead Investors | Other Investors |
|---|---|---|---|---|---|---|
Nov 13, 2019 | 2653594 | PE | 3805499 | 9025726 | 9596527 | 2354080 |
View details of Akums's funding rounds and investors
Akums' founders and board of directors
Founder? Claim ProfileThe founders of Akums are Sandeep Jain and Sanjeev Jain.
Here are the details of Akums' key team members:
- Sandeep Jain: Co-Founder & MD of Akums and founder of 1 other company. They are also an angel investor in 11 startups and serve on the boards of 2 companies.Contact Info: 1 email address
- Sanjeev Jain: Co-Founder & Director of Akums. They are also an angel investor in 2 startups and serve on the boards of 4 companies.Contact Info: 1 phone number
Akums' Board of Directors
Akums's board has 7 active members. Sandeep Jain, Sanjeev Jain, Vijaypal Singh Rawat and Neena Vivek are part of team and Nand Lal, Neena Mohan and Narendra Dev are independent board members.Here is the list of Akums' board of directors:
Name | Type | Representing | Status | Duration |
|---|---|---|---|---|
Team | - | Current | 22y 5m | |
epkica{ | Team | - | Past | 1y 8m |
fne{vay | Team | - | Current | 6y 3m |
mmv{xhu | Team | - | Current | 5y 8m |
eorwoch | Team | - | Past | 2y 3m |
Independent board member | - | Current | 14y 4m | |
sxciblz | Independent board member | - | Current | 6y 5m |
xwzobzh | Independent board member | - | Current | 7y 2m |
tuin{xp | Independent board member | - | Past | 8y 5m |
asuioch | Independent board member | - | Past | 4y 7m |
{g{bdje | Independent board member | - | Past | 8y 3m |
lyfucsv | Independent board member | - | Past | 2y 7m |
View details of Akums's Founder profiles and Board Members
Akums' employee count trend
Akums has 1,802 employees as of Mar 26. Here is Akums's employee count trend over the years:
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Akums's Competitors and alternates
Top competitors of Akums include Jubilant Life Sciences, Nivagen Pharmaceuticals and Leukocare. Here is the list of Top 10 competitors of Akums, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | CDMO focusing on spectrum of dosage forms and therapeutic segments | $70M | 65/100 | ||
2nd | Jubilant Life Sciences 1978, Noida (India), Public | Company offering a suite of R&D and manufacturing services for small molecules and generics | - | 59/100 | |
3rd | Nivagen Pharmaceuticals 2009, Sacramento (United States), Acquired | Developer and contract manufacturer of generic drugs, tablets, capsules, ointment and solution | $31M | 58/100 | |
4th | Developer of proprietary stabilizing and protecting solutions for biologics formulation | $17.5M | 57/100 | ||
5th | Contract services for pharmaceutical development and manufacturing | - | 54/100 | ||
6th | Contract laboratory and contract manufacturing services for pharmaceutical and animal health industries | - | - | 54/100 | |
7th | Chugai Pharmaceutical 1925, Tokyo (Japan), Acquired | Developer of innovative pharmaceutical products and services | - | 54/100 | |
8th | Pontika Aerotech 2017, Paonta Sahib (India), Series A | Contract manufacturer of formulations | $13.8M | 53/100 | |
9th | Asahi Kasei 1931, Chiyoda-ku (Japan), Public | CDMO focused on manufacturing of liquid, solid & injectable drug formulations | - | 53/100 | |
10th | Halo Pharma 2006, Hanover (United States), Acquired | CDMO offering integrated drug development services | $25M | 52/100 |
Looking for more details on Akums's competitors? Click here to see the top ones
Akums's Investments and acquisitions
Akums has made 3 investments in companies including Medibox and Medibox. Akums has also acquired 3 companies including Ankur Drugs and Parabolic Drugs.Here is the list of investments & acquisitions:
Date of Investment/Acquisition | Type | Company Name | Founded Year | Location |
|---|---|---|---|---|
Apr 26, 2022 | Acquisition | 1997 | Mumbai (India) | |
Sep 14, 2019 | Investments | 2016 | Bengaluru (India) | |
Apr 2019 | Acquisition | 1996 | Chandigarh (India) |
See all acquisitions by Akums
Reports related to Akums
Here is the latest report on Akums's sector:
News related to Akums
Media has covered Akums for a total of 12 events in the last 1 year, 3 of them have been about company updates and 1 about people movement.
•
Akums Launches New Moisturization Formulations for Winter Skincare SeasonMedia Bulletins•Oct 09, 2026•Akums
•
Akums Drugs & Pharmaceuticals Reports 58% Jump in Q1 Consolidated Net ProfitUdaipur Kiran•Aug 10, 2026•Akums
•
Akums Arm to Acquire Oriflame India's Manufacturing Facilities for Rs 56 CroreMedical Dialogues•Jul 26, 2026•Akums, Oriflame
•
•
Akums Subsidiaries Face Rs 22 Crore Income Tax Demands for Expenditure DisallowancesMedical Dialogues•May 23, 2026•Akums
•
Akums Reports Strong Q4 FY26 Performance; EBITDA Surges 62%, Board Recommends DividendIndiaMedToday•May 15, 2026•Akums
•
Akums Launches Advanced Antibiotic Aztreonam-Avibactam to Tackle Drug-Resistant InfectionsIndiaMedToday•Apr 28, 2026•Akums
•
Akums Secures EU GMP Certification for Two Manufacturing Facilities in IndiaContract Pharma•Feb 23, 2026•Akums
•
•
Are you a Founder ?
FAQs about Akums
Explore our recently published companies
- Hallway Talk - Denver based, 2014 founded, Unfunded company
- Shalom Hills - Gurugram based, 2004 founded, Unfunded company
- The Space Station - Unfunded company
- Ralph van Roosmalen - Unfunded company
- Universidad Virtual Hispanica de Mexico - Mexico based, Unfunded company
- BRANDOW'S FEED & SEED - Oneonta based, 2005 founded, Unfunded company